Search Within

Elisa De Stanchina

  1. "Shweta Chavan"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (13)
  3. Department of Medicine (13)
  4. GSK Faculty (13)
  5. Sloan Kettering Institute Postdocs (13)
  6. Solid Tumor Oncology Division (13)

More Groups

People
  1. Charles Rudin (13)
  2. Shweta Chavan (13)
  3. Nisargbhai Shah (12)
  4. Triparna Sen (12)
  5. Parvathy Manoj (11)
  6. Jacklynn Egger (10)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (7)
Publications
  1. Annals of Oncology (2)
  2. Cancer Research (2)
  3. Journal of Thoracic Oncology (2)
  4. Cancer Discovery (1)
  5. Cell Reports (1)
  6. Genome Medicine (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Cell Press (3)
  3. Biomed Central Ltd (2)
  4. Elsevier Inc. (2)
  5. Oxford University Press (2)
  6. Nature Publishing Group (1)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library
    Journal Article

    Offin, M.; Sauter, J. L.; Tischfield, S. E.; Egger, J. V.; Chavan, S.; Shah, N. S.; Manoj, P.; Ventura, K.; Allaj, V.; de Stanchina, E.; more...
    Genome Medicine (2022)

    Fulltext@MSK | Save
  • WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
    Journal Article

    Taniguchi, H.; Caeser, R.; Chavan, S. S.; Zhan, Y. A.; Chow, A.; Manoj, P.; Uddin, F.; Kitai, H.; Qu, R.; Hayatt, O.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Journal Article

    Caeser, R.; Egger, J. V.; Chavan, S.; Socci, N. D.; Byrne Jones, C.; Kombak, F. E.; Asher, M.; Roehrl, M. H.; Shah, N. S.; Allaj, V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Inhibition of XPO1 sensitizes small cell lung cancer to first- and second-line chemotherapy
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Chavan, S. S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
    Journal Article

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    iScience (2021)

    Fulltext@MSK | Save
  • Multiomic analysis of lung tumors defines pathways activated in neuroendocrine transformation
    Journal Article

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y. A.; Hasan, M. M.; Chavan, S. S.; Meng, F.; Uddin, F.; Manoj, P.; Donoghue, M. T. A.; Won, H. H.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y.; Hasan, M.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save